FDA 483 - Agupunt USA Corp - March 25, 2026
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Agupunt USA Corp, an importer of dry needling devices in Miami, FL, was cited for significant deficiencies during an FDA inspection. The firm failed to adequately implement procedures for Medical Device Reporting (MDR) by not evaluating complaints for reportability and lacking a functional Electronic Submission Gateway account. Additionally, the inspection revealed a critical gap in supply chain controls, as the firm lacked established inspection and release requirements for imported products upon their arrival in the U.S. warehouse, potentially allowing non-conforming devices to reach patients.
- Office
- Florida District Office
- Person
ID · 2fcbae4a-3e59-4d4e-855e-85b73e671acc